Manish Babulal Jain
About Manish Babulal Jain
Data last updated:
Manish Babulal Jain is a Director at Naprod Life Sciences Private Limited (since 2018), Director at Mac-Chem Products (India) Private Limited (since 2007) and Director at Samrudh Pharmaceuticals Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹540 Cr; the largest is Naprod Life Sciences Private Limited at ₹220 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Naprod Life Sciences Private Limited U24230MH1990PTC057496 | Director | 11 Sep 2018 | 1990 | ₹220 Cr (FY 2025) | Active |
_PRIVATE_LIMITED.webp){kind=small} Mac-Chem Products (India) Private Limited U24239MH1991PTC062948 | Director | 01 Nov 2007 | 1991 | ₹168 Cr (FY 2025) | Active |
 Samrudh Pharmaceuticals Private Limited U24239MH1991PTC061667 | Director | 08 Jan 2021 | 1991 | ₹101 Cr (FY 2025) | Active |
 Vanquest Pharma Private Limited U24304MH2019PTC326607 | Director | 12 Jun 2019 | 2019 | ₹39.34 Cr (FY 2025) | Active |
 Miracalus Pharma Private Limited U24230MH2007PTC171043 | Director | 11 Sep 2018 | 2007 | ₹12.12 Cr (FY 2025) | Active |
| Medorbis Trade Llp AAM-7117 | Designated Partner | 26 May 2018 | 2018 | Active |
Board colleagues of Manish Babulal Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aarya Mohan Jain | 11000730 | Naprod Life Sciences Private Limited , Mac-Chem Products (India) Private Limited and 3 more | Director |
| Mohan Babulal Jain | 00054461 | Naprod Life Sciences Private Limited , Mac-Chem Products (India) Private Limited and 4 more | Director |
| Alok Sharad Sheth | 01330043 | Samrudh Pharmaceuticals Private Limited | Whole-Time Director |
| Sharad Himatlal Sheth | 01742585 | Samrudh Pharmaceuticals Private Limited | Whole-Time Director |
| Hiten Patel | 01212873 | Vanquest Pharma Private Limited | Director |
| Pavan H Patel | 03439561 | Vanquest Pharma Private Limited | Director |
| Pratik Hitenkumar Patel | 03369116 | Vanquest Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Babulal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Babulal Jain
Manish Babulal Jain currently holds 6 directorships: Naprod Life Sciences Private Limited (Director, since 11 Sep 2018, revenue ₹220 Cr (FY 2025)); Mac-Chem Products (India) Private Limited (Director, since 01 Nov 2007, revenue ₹168 Cr (FY 2025)); Samrudh Pharmaceuticals Private Limited (Director, since 08 Jan 2021, revenue ₹101 Cr (FY 2025)); Vanquest Pharma Private Limited (Director, since 12 Jun 2019, revenue ₹39.34 Cr (FY 2025)); Miracalus Pharma Private Limited (Director, since 11 Sep 2018, revenue ₹12.12 Cr (FY 2025)); and 1 more.
Manish Babulal Jain was first appointed on 01 Nov 2007 as Director at Mac-Chem Products (India) Private Limited. The most recent appointment on record is 08 Jan 2021 at Samrudh Pharmaceuticals Private Limited.
The 5 current companies of Manish Babulal Jain that report revenue have a combined latest revenue of ₹540 Cr: Naprod Life Sciences Private Limited ₹220 Cr (FY 2025); Mac-Chem Products (India) Private Limited ₹168 Cr (FY 2025); Samrudh Pharmaceuticals Private Limited ₹101 Cr (FY 2025); Vanquest Pharma Private Limited ₹39.34 Cr (FY 2025); Miracalus Pharma Private Limited ₹12.12 Cr (FY 2025).
The current boards of Manish Babulal Jain's companies include Aarya Mohan Jain (Naprod Life Sciences Private Limited), Mohan Babulal Jain (Naprod Life Sciences Private Limited), Alok Sharad Sheth (Samrudh Pharmaceuticals Private Limited), Sharad Himatlal Sheth (Samrudh Pharmaceuticals Private Limited), Hiten Patel (Vanquest Pharma Private Limited), Pavan H Patel (Vanquest Pharma Private Limited), among others.